Non-invasive Diagnosis of Pulmonary Embolism by Use of Biomarkers in Exhaled Breath Condensate

CompletedOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

April 8, 2019

Primary Completion Date

May 30, 2020

Study Completion Date

May 31, 2020

Conditions
Pulmonary Embolism
Interventions
DIAGNOSTIC_TEST

Test of biomarkers for PE in EBC

"New method for diagnosis of pulmonary embolism (PE) in order to validate/consolidate 151 putative identified biomarkers for PE in the exhaled breath condensate (EBC).~The EBC will be collected by use of the RTube(R) system which has been used in previous studies of EBC. As the patient breathes through a mouth piece, the exhaled breath is led through a cooling chamber where the vaporous part of the exhaled breath condenses.~We aim at collecting a total minimum of 3.0 mL EBC per study subject in order to have a sufficient amount of protein for the subsequent analysis. We aim at collecting exhaled breath condensate for 2\*15 minutes with the possibility to stop the collection after less than 15 minutes if the volume is sufficient."

Trial Locations (1)

9000

Aalborg Hospital, Aalborg

All Listed Sponsors
collaborator

University of Aarhus

OTHER

lead

Aalborg University Hospital

OTHER

NCT04010760 - Non-invasive Diagnosis of Pulmonary Embolism by Use of Biomarkers in Exhaled Breath Condensate | Biotech Hunter | Biotech Hunter